Eleva Capital SAS
13F holdings for Q2 2026 · PARIS, I0 · filed July 2, 2026
Eleva Capital SAS reported $344M in 13F securities across 24 holdings for Q2 2026, in a Form 13F filed July 2, 2026. The largest positions were CRH PLC Ord (81.1%), Amer Sports Inc (2.9%), NVDA (2.6%). Reported value rose 0.0% from the quarter before.
- 13F value Q2 2026
- $344M
- Holdings
- 24
- Change vs prior quarter
- +0.0%
- Rank by 13F value
- #4,864
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| CRH PLC Ord | $279M | 81.1% | 2,654,974 | 0% | Unchanged |
| Amer Sports Inc | $9.8M | 2.9% | 298,802 | 0% | Unchanged |
| NVDA NVIDIA Corporation | $9.1M | 2.6% | 52,002 | 0% | Unchanged |
| NFLX Netflix Inc. | $8.4M | 2.4% | 87,190 | 0% | Unchanged |
| GOOGL Alphabet Inc. | $8.0M | 2.3% | 27,967 | 0% | Unchanged |
| TSM Taiwan Semiconductor Manufacturing Company Ltd. | $6.5M | 1.9% | 21,411 | 0% | Unchanged |
| ANET Arista Networks Inc. | $5.8M | 1.7% | 46,957 | 0% | Unchanged |
| AMZN Amazon.com Inc. | $3.4M | 1.0% | 16,155 | 0% | Unchanged |
| TMUS T-Mobile US Inc. | $3.0M | 0.9% | 14,347 | 0% | Unchanged |
| HOOD Robinhood Markets Inc. | $2.2M | 0.6% | 31,625 | 0% | Unchanged |
| On HLDG AG | $1.7M | 0.5% | 50,150 | 0% | Unchanged |
| BSX Boston Scientific Corporation | $1.7M | 0.5% | 26,667 | 0% | Unchanged |
| Spotify Technology S A | $1.3M | 0.4% | 2,715 | 0% | Unchanged |
| Newamsterdam Pharma Co NV | $823K | 0.2% | 25,721 | 0% | Unchanged |
| EWTX Edgewise Therapeutics Inc. | $709K | 0.2% | 17,460 | 0% | Unchanged |
| CGON CG Oncology Inc. | $561K | 0.2% | 8,289 | 0% | Unchanged |
| Esperion Therapeutics Inc Ne | $502K | 0.1% | 183,047 | 0% | Unchanged |
| MLYS Mineralys Therapeutics Inc. | $463K | 0.1% | 17,081 | 0% | Unchanged |
| FENC Fennec Pharmaceuticals Inc. | $327K | 0.1% | 53,234 | 0% | Unchanged |
| IRON Disc Medicine Inc. | $327K | 0.1% | 5,115 | 0% | Unchanged |
| VRDN Viridian Therapeutics Inc. | $139K | 0.0% | 7,126 | 0% | Unchanged |
| FCX Freeport-McMoRan Inc. | $133K | 0.0% | 2,258 | 0% | Unchanged |
| ACHR Archer Aviation Inc. | $111K | 0.0% | 21,534 | 0% | Unchanged |
| AQST Aquestive Therapeutics Inc. | $11K | 0.0% | 2,720 | 0% | Unchanged |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $344M in share positions; options and bonds count in the 13F value but not here.
Biggest buys in Q2 2026
None this quarter.
Biggest sells in Q2 2026
None this quarter.
The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 0 new, 0 added, 0 trimmed, 0 sold out.
Sector mix
- Not listed with us85.2%
- Technology6.9%
- Consumer Discretionary3.4%
- Telecommunications2.6%
- Health Care1.2%
- Finance0.6%
- Basic Materials0.0%
- Industrials0.0%
13F value by quarter
Questions about Eleva Capital SAS
- What does Eleva Capital SAS own?
- In its Form 13F for Q2 2026, Eleva Capital SAS reported 24 holdings worth $344M. The five largest were CRH PLC Ord, Amer Sports Inc, NVDA, NFLX, GOOGL.
- What did Eleva Capital SAS buy and sell in Q2 2026?
- Eleva Capital SAS opened 0 new positions, added to 0, trimmed 0 and sold out of 0 compared with the quarter before.
- When did Eleva Capital SAS file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed July 2, 2026.
From Form 13F filed by Eleva Capital SAS (SEC CIK 0002054496) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds · Get this as JSON